Generic drugs generated nearly $193 billion in savings to the U.S. health care system in 2011, according to a report by the General Pharmaceutical Association. The group noted that the figure likely will increase in coming years because a slew of high-price brand-name drugs, such as Lipitor and Zyprexa, had their patents expire recently.
